<p>A high dose orodispersible dosage form of oxcarbazepine is provided. Drug-containing particles of oxcarbazepine are included within a porous bound matrix. The dosage form disperses in saliva or water in less than 15 sec and it has sufficient hardness to withstand handling and storage. It can be used to treat diseases or disorders that are therapeutically responsive to oxcarbazepine or a derivative thereof.</p>
申请公布号
EP2968354(A4)
申请公布日期
2016.01.20
申请号
EP20140763545
申请日期
2014.03.14
申请人
APRECIA PHARMACEUTICALS COMPANY
发明人
JACOB, JULES;CAPUTO, KELLY;GUILLOT, MICAEL;SULTZBAUGH, KENNETH, J.;WEST, THOMAS, G.